Verrica Pharmaceuticals Inc. Gains 35.62%
Fri, Nov 28, 2025 at 07:43 PM
Verrica Pharmaceuticals Inc. (VRCA:NASDAQ) shot up at $9.1, representing a gain of 35.6%. On Fri, Nov 28, 2025, VRCA:NASDAQ touched a New 2-Week High of $9.1. The stock got featured on our News Catalysts scanner on Mon, Nov 24, 2025 at 10:47 AM in the 'PRIVATE PLACEMENT' category. From Fri, Nov 14, 2025, the stock recorded 77.78% Up Days and 70.00% Green Days
About Verrica Pharmaceuticals Inc. (VRCA:NASDAQ)
Verrica Pharmaceuticals Inc a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.
Top 10 Gainers:
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 250.8%
- Twin Vee Powercats Co. (VEEE:NASDAQ), 45.51%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 38.68%
- Verrica Pharmaceuticals Inc. (VRCA:NASDAQ), 35.62%
- Apimeds Pharmaceuticals US, Inc (APUS:NYSEMKT), 32.42%
- Nature Wood Group Limited (NWGL:NASDAQ), 30.56%
- OneMedNet Corporation (ONMD:NASDAQ), 30.28%
- HeartBeam, Inc. (BEAT:NASDAQ), 27.55%
- Next Technology Holding Inc. (NXTT:NASDAQ), 24.89%
- Falcon's Beyond Global, Inc. (FBYD:NASDAQ), 23.91%